.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Citi
Teva
Cerilliant
Accenture
Daiichi Sankyo
UBS
Medtronic
Harvard Business School

Generated: June 25, 2017

DrugPatentWatch Database Preview

DYAZIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Dyazide, and what generic Dyazide alternatives are available?

Dyazide is a drug marketed by Glaxosmithkline Llc and is included in one NDA.

The generic ingredient in DYAZIDE is hydrochlorothiazide; triamterene. There are thirty-one drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.

Summary for Tradename: DYAZIDE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list77
Clinical Trials: see list1
Patent Applications: see list30
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DYAZIDE at DailyMed

Pharmacology for Tradename: DYAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Llc
DYAZIDE
hydrochlorothiazide; triamterene
CAPSULE;ORAL016042-003Mar 3, 1994ABRXYesYes► Subscribe► Subscribe
Glaxosmithkline Llc
DYAZIDE
hydrochlorothiazide; triamterene
CAPSULE;ORAL016042-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Teva
Dow
Farmers Insurance
US Department of Justice
Cipla
UBS
McKesson
Novartis
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot